• Dry Cracked Skin
  • General Dermatology
  • Impetigo
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Surgery
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Inflamed Skin

Eczema Global Scorecard: Patients Struggling to Control Symptoms


Korey Capozza, MPH, the founder and executive director of Global Parents for Eczema Research dives into the importance of the results from their recently released study.

Emphasizing shared decision-making on treatment and looking for ways to train patients to address flares are great ways that dermatologists can help their patients with their atopic dermatitis, according to a speaker at this weekend's Revolutionizing Atopic Dermatitis meeting in Baltimore, Maryland.

Korey Capozza, MPH, who is the founder and executive director of Global Parents for Eczema Research, spoke with Dermatology Times® in an exclusive interview about the global report card of eczema patient care in eight countries.

"Poorly controlled eczema that can't be fully addressed by existing treatments substantially impacts patients' health-related quality of life," according to a press release about the survey from the organization. "Based on adult patients' descriptions of their health, they would give up between 17% to 36% of their remaining life span in order to be restored to perfect health."

Capozza noted that pain and the mental health impacts of this condition were often cited as negatively impacting patients' quality of life.

Hear more in the results below.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.